Iovance Biotherapeutics Inc
Change company Symbol lookup
Select an option...
IOVA Iovance Biotherapeutics Inc
SWZ Swiss Helvetia Fund Inc
BALL Ball Corp
KIIIW Kismet Acquisition Three Equity Warrant Exp 30 June 2026 *W EXP 06/30/2026
SG Sweetgreen Inc
MAXN Maxeon Solar Technologies Ltd
PARAP Paramount Global
INT World Fuel Services Corp
NGD New Gold Inc
CRT Cross Timbers Royalty Trust

Health Care : Biotechnology | Small Cap Blend
Company profile

Iovance Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of cell therapies as cancer immunotherapy products designed to harness the power of a patient’s own immune system to eradicate cancer cells. It has developed a new, shorter manufacturing process for tumor infiltrating lymphocyte (TIL) known as Generation 2 (Gen 2), which yields a cryopreserved TIL product. Its lead product candidates include lifileucel for metastatic melanoma and metastatic cervical cancer, as well as LN-145 for metastatic non-small cell lung cancer (NSCLC). In addition, the Company is investigating the combinations of TIL therapy with immune checkpoint inhibitors (ICIs) in metastatic melanoma, cervical cancer (NSCLC), and head and neck squamous cell carcinoma (HNSCC). It is investigating peripheral blood lymphocyte (PBL) therapy for patients with refractory chronic lymphocytic leukemia (CLL) and small lymphocytic lymphoma (SLL).

Closing Price
Day's Change
0.43 (3.89%)
B/A Size
Day's High
Day's Low

10-day average volume:
  • Prev Close
  • Today's Open
  • Day's Range
  • Avg Vol (10-day)
  • Last (time)
    4:00p ET 07/01/22
  • Last (size)
  • 52-Wk Range
    6.18 - 27.96
  • (10/14/21 - 06/02/22)
  • 104.3%
  • Market Cap
  • Shares Outstanding
  • -2.30
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.5
  • 102.57
  • (% of float 06/15/22)

Latest News

June 17, 2022
5:15 pm ET
Globe Newswire
June 13, 2022
4:01 pm ET
Globe Newswire
June 08, 2022
4:01 pm ET
Globe Newswire
June 03, 2022
10:55 am ET
PR Newswire
May 29, 2022
8:54 am ET
May 27, 2022
10:59 am ET
PR Newswire
7:14 am ET
6:52 am ET
May 26, 2022
4:29 pm ET
4:01 pm ET
Globe Newswire
May 20, 2022
5:15 pm ET
Globe Newswire
May 05, 2022
4:01 pm ET
Globe Newswire
April 27, 2022
4:01 pm ET
Globe Newswire
April 26, 2022
7:30 am ET
Globe Newswire
April 25, 2022
4:01 pm ET
Globe Newswire
April 22, 2022
5:15 pm ET
Globe Newswire
April 12, 2022
5:00 pm ET
Globe Newswire
April 05, 2022
4:05 pm ET
Globe Newswire
January 28, 2022
6:55 am ET
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.